CARLSBAD, CA--(Marketwire - Nov 6, 2012) - International Stem Cell Corporation ( OTCQB : ISCO ) http://www.internationalstemcell.comannounced today that it will host a conference call on Friday, November 9, 2012 to discuss its financial results for the three months ended September 30, 2012. Dr. Simon Craw, Executive Vice President of International Stem Cell, and Ms. Linh Nguyen, Chief Financial Officer, will host the conference call. To attend the call, please use the dial in information below: Date: Friday, November 9, 2012 Time: 11:00 a.m. Eastern Time Conference Line (U.S.): 1-877-317-6776 International Dial-In: 1-412-317-6776 Conference ID: 10020806 Webcast: http://webcast.mzvaluemonitor.com/Home/Login/630 Please dial in at least 10-minutes before the call to ensure timely participation. A playback of the call will be available until 9:00 a.m. ET on November 26, 2012. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10020806. About International Stem Cell Corporation International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues … Continue reading
Categories
- Aesthetic Medicine
 - Aesthetic Surgery
 - Ai
 - ALS Treatment
 - Anatomy
 - Artificial General Intelligence
 - Artificial Intelligence
 - Artificial Super Intelligence
 - Batten Disease Treatment
 - BioEngineering
 - BioInformatics
 - Biology
 - Biotechnology
 - Bitcoin
 - Brain Injury Treatment
 - Cardiac Nursing
 - Cardiac Regeneration
 - Cardiac Remodeling
 - Cardiac Rhythm Abnormalities
 - Cardiac Surgery
 - Cardiology
 - Cardiomyopathies
 - Cardiovascular Pharmacology
 - Cell Medicine
 - Cell Therapy
 - Cerebral Palsy
 - Cerebral Palsy Treatment
 - Cheap Pharmacy
 - Chemistry
 - Clinical Cardiology
 - Coronary Heart Diseases
 - Cryptocurrency
 - DNA
 - Drug Dependency
 - Drug Side Effects
 - Drugs
 - Eczema
 - Elon Musk
 - Embryology
 - Erectile Dysfunction
 - FDA Stem Cell Trials
 - Femtomedicine
 - Future Medicine
 - Gene Medicine
 - Gene Therapy
 - Gene Therapy Trials
 - Genetic Engineering
 - Genetic Therapy
 - Genetics
 - Germ Line Engineering
 - Heart Diseases
 - HGH
 - Hgh Injections
 - Hormone Replacement Therapy
 - Human Genetics
 - Human Growth Hormone
 - Human Immortality
 - Hyperbaric Medicine
 - Hypertension
 - Hypothalamus
 - Impotency
 - Internet Pharmacy
 - Interventional Cardiology
 - IVF Treatment
 - Lyme Disease
 - Male Sexual Dysfunction
 - Mars Colony
 - Medical Business
 - Medical School
 - Medical Technology
 - Medicine
 - Mental Health
 - Mesenchymal Stem Cells
 - Micropenia
 - Molecular Cardiology
 - MS Treatment
 - Muscular Dystrophy Treatment
 - Myocardial Infarction
 - Nanotechnology
 - Online Pharmacy
 - Oral Health
 - Parkinson's Treatment
 - Pediatric Cardiology
 - Penis Enlargement
 - Pet Stem Cell Therapy
 - Pharmacy
 - Picomedicine
 - Premature Ejaculation
 - Prescriptions
 - Retinitis Pigmentosa
 - Sermorelin
 - Singularity
 - Sleep
 - Spacex
 - Spinal Cord Injury Treatment
 - Stem Cell Clinical Trials
 - Stem Cell Experiments
 - Stem Cell Human Trials
 - Stem Cell Injections
 - Stem Cell Research
 - Stem Cell Transplant
 - Stem Cell Treatments
 - Testosterone
 - Ulcerative Colitis
 - Uncategorized
 - Vascular Biology
 - Ventricular Remodeling
 - Wholesale Pharmacy
 
Archives